FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Jul 29, 2009
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on July 29, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- July 29, 2009
- Product Type
- Biologics
View Company Profile
ID · 93f69df0-ee0a-4cae-a225-a5bdbe39e954
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 602283
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 17, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 30, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 6, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1177924 - 2022-08-17
- FDA Inspection 1057030 - 2018-05-30
- FDA Inspection 881284 - 2014-06-06
- FDA Inspection 789152 - 2012-06-15
- FDA Inspection 677941 - 2010-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.